a check mark secured on both the formulation technology and the pharmacological mode of action established in early drug discovery, we are confident in the ongoing success of TPT0701 as it progresses through development," added Morten Allesø....
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient™. The standardized and automated platform streamlines the assessment and validation of large...
by multiple measures. Key features of MASH are conserved in the tissue and allow for superior disease understanding, drug discovery and development. MASH is the new clinical term introduced in 2023 to replace NASH (non-alcoholic steatohepatitis)....
